SCHEMBL17215522

SCHEMBL17215522

Cc1ccc(N)c2c1C(C)(C)CC2C

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.36
CD44 P16070 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4818512 0.86 ALDH1A1 (0.30) MAPT
SCHEMBL19358655 0.80 BACE1 (0.34)
SCHEMBL23143296 0.80 BACE1 (0.34)
SCHEMBL19378726 0.80 BACE1 (0.34)
SCHEMBL17216551 0.76 ALDH1A1 (0.31)
SCHEMBL30197891 0.74 ALDH1A1 (0.41) MAPTCD44
SCHEMBL16991796 0.74 ALDH1A1 (0.41) MAPTCD44
SCHEMBL8626918 0.74 ALDH1A1 (0.41) MAPTCD44
SCHEMBL2779868 0.74 ALDH1A1 (0.41) MAPTCD44
SCHEMBL29522211 0.74 ALDH1A1 (0.41) MAPTCD44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105408302-B The method for preparing the amines of purified form 住友化学株式会社 2017-06-13 CN disclosed
EP-2940001-B1 METHOD FOR PRODUCING PURIFIED FORM OF AMINE COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-05-03 EP disclosed
US-9493418-B2 Method for producing purified amine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-11-15 US disclosed
CN-105408302-A Method for producing purified form of amine compound SUMITOMO CHEMICAL CO 2016-03-16 CN disclosed
US-20150344431-A1 METHOD FOR PRODUCING PURIFIED AMINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-12-03 US disclosed
EP-2940001-A1 METHOD FOR PRODUCING PURIFIED FORM OF AMINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2015-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344431-A1 METHOD FOR PRODUCING PURIFIED AMINE COMPOUND SRM, ADH1C, H1-0 MAPT 1027/4885CD44 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.